Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Franciosi · SciRah

Researcher profile · Semantic Scholar

V. Franciosi

Share profile

V. Franciosi — researcher profile on SciRah

h-index: 20
Works: 48
Citations: 1,027

Most-cited papers

Front‐line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma
V. Franciosi, G. Cocconi, M. Michiara, F. di Costanzo +5 more
1999Cancer229 citations Open access
Semantic Scholar
Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): study of a comprehensive panel of molecular markers.
M. Tiseo, G. Rossi, M. Capelletti, G. Sartori +11 more
2010Lung Cancer78 citations
Semantic Scholar
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S. Cascinu, M. Scartozzi, R. Labianca, V. Catalano +10 more
2004British Journal of Cancer72 citations Open access
Semantic Scholar
Comparison Between Epidermal Growth Factor Receptor (EGFR) Gene Expression in Primary Non-small Cell Lung Cancer (NSCLC) and in Fine-Needle Aspirates from Distant Metastatic Sites
C. Bozzetti, M. Tiseo, C. Lagrasta, R. Nizzoli +10 more
2008Journal of Thoracic Oncology61 citations Open access
Semantic Scholar
Early palliative care and quality of life of advanced cancer patients-a multicenter randomized clinical trial.
V. Franciosi, G. Maglietta, Claudia Degli Esposti, G. Caruso +14 more
2019Annals of Palliative Medicine53 citations Open access
Semantic Scholar
HER‐2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma
C. Bozzetti, N. Personeni, R. Nizzoli, A. Guazzi +7 more
2003Cancer44 citations Open access
Semantic Scholar
Adjuvant chemotherapy for non-small cell lung cancer: ready for clinical practice?
M. Tiseo, V. Franciosi, F. Grossi, A. Ardizzoni
2006European Journal of Cancer39 citations
Semantic Scholar
Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients.
M. Scartozzi, V. Franciosi, N. Campanini, G. Benedetti +10 more
2006Lung Cancer37 citations
Semantic Scholar
Activity and safety of dose‐adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor‐prognostic untreated diffuse large B‐cell non‐Hodgkin lymphoma
A. Musolino, D. Boggiani, Michele Panebianco, G. Vasini +3 more
2011Cancer33 citations Open access
Semantic Scholar
Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients.
V. Franciosi, R. Barbieri, E. Aitini, G. Vasini +4 more
2003Lung Cancer33 citations
Semantic Scholar
Epidermal Growth Factor Receptor Intron-1 Polymorphism Predicts Gefitinib Outcome in Advanced Non-small Cell Lung Cancer
M. Tiseo, M. Capelletti, G. de Palma, V. Franciosi +13 more
2008Journal of Thoracic Oncology32 citations Open access
Semantic Scholar
Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
F. Cappuzzo, S. Novello, F. de Marinis, V. Franciosi +10 more
2005British Journal of Cancer28 citations Open access
Semantic Scholar
Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial.
M. D. Chiesa, R. Passalacqua, M. Michiara, V. Franciosi +6 more
2007Acta bio-medica : Atenei Parmensis27 citations
Semantic Scholar
The Combination of Gemcitabine and Vinorelbine is an Active Regimen as Second-Line Therapy in Patients with Metastatic Breast Cancer Pretreated with Taxanes and/or Anthracyclines: a Phase I–II Study
A. Morabito, G. Filippelli, S. Palmeri, S. Cascinu +9 more
2003Breast Cancer Research and Treatment26 citations
Semantic Scholar
Capecitabine and Mitomycin c May be an Effective Treatment Option for Third-line Chemotherapy in Advanced Colorectal Cancer
M. Scartozzi, A. Falcone, F. Pucci, C. Braconi +10 more
2006Tumori23 citations
Semantic Scholar
Early Detection of Recurrences in the Follow-up of Primary Breast Cancer in an Asymptomatic or Symptomatic Phase
M. Perrone, A. Musolino, M. Michiara, Beatrice Di Biasio +6 more
2004Tumori23 citations
Semantic Scholar
Early Integration of Palliative Care in Oncology Practice: Results of the Italian Association of Medical Oncology (AIOM) Survey
V. Zagonel, R. Torta, V. Franciosi, A. Brunello +24 more
2016Journal of Cancer21 citations Open access
Semantic Scholar
The value of bone marrow biopsy in breast cancer at time of diagnosis. A prospective study
G. Ceci, V. Franciosi, R. Nizzoli, V. De Lisi +6 more
1988Cancer21 citations
Semantic Scholar
Position Paper of the Italian Association of Medical Oncology on Early Palliative Care in Oncology Practice (Simultaneous Care)
V. Zagonel, V. Franciosi, A. Brunello, G. Biasco +28 more
2017Tumori20 citations Open access
Semantic Scholar
Buccal Mucosa Cells as In vivo Model to Evaluate Gefitinib Activity in Patients with Advanced Non–Small Cell Lung Cancer
M. Loprevite, M. Tiseo, M. Chiaramondia, M. Capelletti +15 more
2007Clinical Cancer Research20 citations Open access
Semantic Scholar
The Medical Oncologist's Role in Palliative Care: AIOM's Position
V. Zagonel, L. Cavanna, G. Cetto, M. Ciaparrone +12 more
2009Tumori18 citations
Semantic Scholar
HER-2/neu Evaluation by Fluorescence in Situ Hybridization on Destained Cytologic Smears from Primary and Metastatic Breast Cancer
R. Nizzoli, A. Guazzi, N. Naldi, V. Franciosi +1 more
2005Acta Cytologica17 citations
Semantic Scholar
Molecular Profile and Clinical Variables in Brca1-Positive Breast Cancers. A Population-Based Study
A. Musolino, M. Michiara, M. Bella, N. Naldi +11 more
2005Tumori16 citations
Semantic Scholar
Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non‐small cell lung cancer: A phase II study of the Italian oncology group for clinical research (goirc)
C. Boni, G. Bisagni, L. Savoldi, G. Moretti +9 more
2000International Journal of Cancer10 citations Open access
Semantic Scholar
The value of bone marrow biopsy in breast cancer at the time of first relapse. A prospective study
G. Ceci, V. Franciosi, R. Passalacqua, B. di Blasio +6 more
1988Cancer9 citations Open access
Semantic Scholar
Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO‐P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non‐Hodgkin lymphoma
A. Musolino, M. Perrone, M. Michiara, D. Delnevo +6 more
2005Cancer8 citations Open access
Semantic Scholar
Biological parameters on computed tomography guided fine needle aspiration biopsy from peripheral primary non-small cell lung cancer.
C. Bozzetti, R. Nizzoli, A. Guazzi, V. Franciosi +4 more
2002Lung Cancer7 citations
Semantic Scholar
Compliance and Outcomes in Locally Advanced Head and Neck Cancer Patients Treated with Alternating Chemoradiotherapy in Clinical Practice
V. Franciosi, M. Fumagalli, L. Biscari, R. Martinelli +11 more
2003Tumori5 citations
Semantic Scholar
The combination of gemcitabine and oxaliplatin (GEM-OXAL) is feasible in patients with poor prognosis advanced non-small cell lung cancer (NSCLC). Results of a phase II study
V. Franciosi, R. Barbieri, G. Vasini, E. Aitini +5 more
20015 citations
Semantic Scholar
Bone Marrow Biopsy in the Staging of Small Cell Lung Cancer
V. Franciosi, G. Bisagni, G. Ceci, C. Boni +5 more
1989Tumori5 citations
Semantic Scholar
P3.01-004 Exceptional Evolution of Benign Metastasizing Leiomyomas of the Lung: Topic: Morphology
L. Ventura, L. Gnetti, V. Franciosi, Cesare Braggio +5 more
20172 citations Open access
Semantic Scholar
Physical exercises programs for cancer patients: what else’s new?
F. Rodà, F. Petraglia, Veronica Scaltriti, C. Costantino +3 more
20171 citations Open access
Semantic Scholar
P-CHOP: Cisplatin (P) Added to the Standard CHOP Regimen as First-Line Treatment for Aggressive Non-Hodgkin Lymphoma: A Single-Institution Phase II Study
G. Cocconi, V. Franciosi, A. Dodero, A. Bologna +6 more
2003American Journal of Clinical Oncology1 citations
Semantic Scholar
Treatment of stage IIIB-IV non small cell lung cancer (NSCLC) with Gemcitabine, Ifosfamide, Cisplatin (GIP). A phase II study
C. Boni, G. Bisagni, L. Savoldi, G. Moretti +5 more
19991 citations
Semantic Scholar
[Our experience with the diagnostic and prognostic unreliability of pre- and postoperative CEA in human breast cancer].
E. Ovaleo-Pandolfo, P. Capelli, V. Franciosi
1985Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma1 citations
Semantic Scholar
palliative careEvaluation of effects of early palliative care on quality of life of advanced cancer patients. A multicenter controlled randomised clinical trial
V. Franciosi, G. Caruso, G. Maglietta, C. D. Esposti +14 more
20160 citations Open access
Semantic Scholar
E01*Effects of simultaneous care on quality of life of advanced cancer patients. A multicenter controlled randomised clinical trial
V. Franciosi, G. Caruso, C. D. Esposti, L. Cavanna +14 more
20160 citations Open access
Semantic Scholar
1134 POSTER Survival prediction of terminally ill cancer patients by clinical and laboratory parameters: usefullness role of simple prognostic indicators
G. Vasini, G. Bacchini, V. Franciosi, C. Ghidini +5 more
20070 citations
Semantic Scholar
Comparison between epidermal growth factor receptor (EGFR) gene in primary non-small cell lung cancer (NSCLC) and in fine needle aspirates from metastatic sites
C. Bozzetti, M. Tiseo, C. Lagrasta, R. Nizzoli +6 more
20070 citations
Semantic Scholar
P-961 Buccal mucosa cells as “in vivo” model to evaluate gefitinib response in NSCLC patients
M. Loprevite, M. Chiaramondia, M. Tiseo, F. Grossi +6 more
20050 citations
Semantic Scholar
[State of the art in the treatment of stage IIIA non-small cell lung tumors].
A. Ardizzoni, V. Franciosi
2004I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.]0 citations
Semantic Scholar
Determination of biological parameters on fine-needle aspirates from non-small cell lung cancer.
C. Bozzetti, A. Guazzi, R. Nizzoli, N. Naldi +2 more
2003Methods in Molecular Medicine0 citations
Semantic Scholar
P-151 Correlations between clinical response to cisplatin or oxaliplatin and expression of the Mismatch Repair (MMR) and p53 in advanced non-small cell lung cancer (NSCLC) patients
V. Franciosi, N. Campanini, C. Bozzetti, A. Perrone +3 more
20030 citations
Semantic Scholar
Concordance between immunocytochemistry and immunohistochemistry in the biological characterization of non-small cell lung cancer (NSCLC)
V. Franciosi, C. Bozzetti, R. Nizzoli, A. Guazzi +4 more
20000 citations
Semantic Scholar
Author reply
V. Franciosi, G. Cocconi
1999Cancer0 citations Open access
Semantic Scholar
Peripheral blood progenitor cell mobilization is significantly enhanced by amifostine
C. Carlo-Stella, A. Dodero, L. Mangoni, V. Franciosi +4 more
19980 citations
Semantic Scholar
203 Intensive CODE regimen for the treatment of limited and extensive stage small cell lung carcinoma
V. Franciosi, G. Vasini, F. Leonardi, G. Ceci +3 more
19970 citations
Semantic Scholar
Merkel cell carcinoma. A clinicopathological study of 3 cases and a review of the literature
G. Bisagni, B. di Blasio, V. Franciosi, R. Lottici +1 more
19880 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Cascinu×15
Invite
S. Cascinu — researcher profile on SciRah
G. Cocconi×12
Invite
G. Cocconi — researcher profile on SciRah
C. Bozzetti×12
Invite
C. Bozzetti — researcher profile on SciRah
R. Camisa×12
Invite
R. Camisa — researcher profile on SciRah

×12

Invite

A. Ardizzoni — researcher profile on SciRah

Invite

R. Nizzoli — researcher profile on SciRah

Invite

A. Guazzi — researcher profile on SciRah

B. di Blasio×8

Invite

B. di Blasio — researcher profile on SciRah

Invite

M. Tiseo — researcher profile on SciRah

Invite

G. Rindi — researcher profile on SciRah

Invite

L. Cavanna — researcher profile on SciRah

Invite

G. Vasini — researcher profile on SciRah